Osteoporosis and Right ventricular hypertrophy

Summary:

Right ventricular hypertrophy is found among people with Osteoporosis, especially for people who are male, 60+ old.

The study analyzes which people have Right ventricular hypertrophy with Osteoporosis. It is created by eHealthMe based on reports of 30 people who have Osteoporosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Osteoporosis?

Osteoporosis (bones weak and more likely to break) is found to be associated with 1,811 drugs and 1,900 conditions by eHealthMe. Check the latest studies of Osteoporosis.

What is Right ventricular hypertrophy?

Right ventricular hypertrophy (right ventricular enlargement) is found to be associated with 233 drugs and 308 conditions by eHealthMe. Check the latest studies of Right ventricular hypertrophy.

On Jul, 13, 2026

30 people who have Osteoporosis and Right Ventricular Hypertrophy are studied.

Would you have Right ventricular hypertrophy when you have Osteoporosis?

Gender of people who have Osteoporosis and experienced Right Ventricular Hypertrophy *:

female: 17.39 %
male: 82.61 %

Age of people who have Osteoporosis and experienced Right Ventricular Hypertrophy *:

Common co-existing conditions for these people *:

High Blood Pressure: 25 people, 83.33%
Asthma: 25 people, 83.33%
Gout (uric acid crystals building up in the body): 24 people, 80.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 24 people, 80.00%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 3.33%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 3.33%
Depression: 1 person, 3.33%
Bone Density Abnormal: 1 person, 3.33%

Common drugs taken by these people *:

Common symptoms for these people *:

Intervertebral Disc Degeneration (spinal disc degeneration): 28 people, 93.33%
Wheezing (a high-pitched whistling sound made while you breath): 28 people, 93.33%
Cough: 28 people, 93.33%
Depression: 28 people, 93.33%
Stress And Anxiety: 28 people, 93.33%
Fatigue (feeling of tiredness): 26 people, 86.67%
Dizziness: 26 people, 86.67%
Dyspnea (difficult or laboured breathing): 25 people, 83.33%
Hypoacusis (loss of hearing): 25 people, 83.33%
Productive Cough: 25 people, 83.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Right ventricular hypertrophy?

- Check whether Right ventricular hypertrophy is associated with a drug or a condition

Related publications that referenced our studies

Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Right ventricular hypertrophy and Osteoporosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.